Clinical Trial

Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial

Study acronym: STORM
Unknown Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 25, 2023 (before its estimated December 25, 2025 completion). Its status may not reflect the trial's current state.
Summary
The main objective is to evaluate the effectiveness of Rituximab monotherapy versus steroid therapy on children with new-onset nephrotic syndrome within the 52-week follow-up.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05734794
Lead Sponsor The Children's Hospital of Zhejiang University School of Medicine
Conditions Nephrotic Syndrome in Children, Rituximab
Enrollment 80 participants
Start Date 2023-02-09
Primary Completion 2025-12-25 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2023-08-25